Indivior (INDV) Competitors GBX 897 -11.00 (-1.21%) (As of 12/11/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades INDV vs. SOPH, HCM, ITH, GRI, SLS, ERGO, BMY, SLN, AMYT, and GPHShould you be buying Indivior stock or one of its competitors? The main competitors of Indivior include Sophos Group plc (SOPH.L) (SOPH), HUTCHMED (HCM), Ithaca Energy (ITH), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Bloomsbury Publishing (BMY), Silence Therapeutics (SLN), Amryt Pharma (AMYT), and Global Ports (GPH). These companies are all part of the "pharmaceutical products" industry. Indivior vs. Sophos Group plc (SOPH.L) HUTCHMED Ithaca Energy Grainger Standard Life UK Smaller Companies Trust Ergomed Bloomsbury Publishing Silence Therapeutics Amryt Pharma Global Ports Indivior (LON:INDV) and Sophos Group plc (SOPH.L) (LON:SOPH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends, community ranking and profitability. Which has higher earnings and valuation, INDV or SOPH? Sophos Group plc (SOPH.L) has lower revenue, but higher earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIndivior£1.15B1.00-£141M-£0.80-1,121.25Sophos Group plc (SOPH.L)£726.90M4.11N/A£1.70341.41 Is INDV or SOPH more profitable? Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to Indivior's net margin of -12.29%. Indivior's return on equity of 12.20% beat Sophos Group plc (SOPH.L)'s return on equity.Company Net Margins Return on Equity Return on Assets Indivior-12.29% 12.20% 2.37% Sophos Group plc (SOPH.L) N/A N/A N/A Do analysts rate INDV or SOPH? Indivior presently has a consensus target price of GBX 1,500, suggesting a potential upside of 67.22%. Given Indivior's stronger consensus rating and higher possible upside, equities analysts clearly believe Indivior is more favorable than Sophos Group plc (SOPH.L).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Indivior 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Sophos Group plc (SOPH.L) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to INDV or SOPH? In the previous week, Indivior's average media sentiment score of 0.00 equaled Sophos Group plc (SOPH.L)'saverage media sentiment score. Company Overall Sentiment Indivior Neutral Sophos Group plc (SOPH.L) Neutral Do insiders & institutionals believe in INDV or SOPH? 86.0% of Indivior shares are owned by institutional investors. 3.4% of Indivior shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is INDV or SOPH a better dividend stock? Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.7%. Sophos Group plc (SOPH.L) pays an annual dividend of GBX 0.04 per share and has a dividend yield of 0.0%. Indivior pays out -1,875.0% of its earnings in the form of a dividend. Sophos Group plc (SOPH.L) pays out 2.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Indivior is clearly the better dividend stock, given its higher yield and lower payout ratio. Does the MarketBeat Community favor INDV or SOPH? Indivior received 141 more outperform votes than Sophos Group plc (SOPH.L) when rated by MarketBeat users. Likewise, 80.40% of users gave Indivior an outperform vote while only 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote. CompanyUnderperformOutperformIndiviorOutperform Votes55880.40% Underperform Votes13619.60%Sophos Group plc (SOPH.L)Outperform Votes41780.19% Underperform Votes10319.81% SummaryIndivior beats Sophos Group plc (SOPH.L) on 12 of the 16 factors compared between the two stocks. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Get Indivior News Delivered to You Automatically Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INDV vs. The Competition Export to ExcelMetricIndiviorDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£1.15B£1.20B£5.27B£1.40BDividend Yield4.48%3.13%5.15%12.29%P/E Ratio-1,121.25114.00136.821,629.03Price / Sales1.002,710.101,245.34337,798.22Price / Cash2.6810.2136.5032.55Price / Book-9.973.044.652.91Net Income-£141M£155.79M£119.47M£126.35M7 Day Performance-0.17%0.08%0.44%4.92%1 Month Performance12.13%-1.90%-1.22%6.34%1 Year Performance-23.85%114.16%32.46%105.52% Indivior Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INDVIndivior1.6924 of 5 starsGBX 897-1.2%GBX 1,500+67.2%-24.1%£1.15B£1.15B-1,121.251,000SOPHSophos Group plc (SOPH.L)N/AGBX 580.40+1.0%N/AN/A£2.99B£726.90M341.41520HCMHUTCHMEDN/AGBX 283+3.7%N/A-8.3%£2.42B£610.81M-6,725.001,760Gap DownITHIthaca EnergyN/AGBX 107.40+0.8%N/A-27.4%£1.77B£1.91B888.33220GRIGrainger3.1128 of 5 starsGBX 230-1.3%GBX 317.50+38.0%-11.7%£1.70B£270.30M8,183.33372High Trading VolumeSLSStandard Life UK Smaller Companies TrustN/AGBX 732-1.3%N/AN/A£715.41M£222.48M3.3710ERGOErgomedN/AGBX 1,346flatN/A+0.0%£701.00M£152.09M4,641.386BMYBloomsbury Publishing1.214 of 5 starsGBX 662-1.2%GBX 825+24.6%+43.9%£539.13M£342.65M1,717.9534,300Gap DownSLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100News CoverageHigh Trading VolumeAMYTAmryt PharmaN/AGBX 143-11.7%N/A+0.0%£457.11M£210.24M-4.33290Gap DownGPHGlobal PortsN/AGBX 300-4.5%N/A+14.5%£231.21M£193.58M30,000.0020 Related Companies and Tools Related Companies Sophos Group plc (SOPH.L) Alternatives HUTCHMED Alternatives Ithaca Energy Alternatives Grainger Alternatives Standard Life UK Smaller Companies Trust Alternatives Ergomed Alternatives Bloomsbury Publishing Alternatives Silence Therapeutics Alternatives Amryt Pharma Alternatives Global Ports Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:INDV) was last updated on 12/11/2024 by MarketBeat.com Staff From Our PartnersWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indivior PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Indivior With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INDV Stock Alerts